Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Assessing the level of radiation experienced by anesthesiologists during transfemoral Transcatheter Aortic Valve Implantation and protection by a lead cap.

Mayr NP, Wiesner G, Kretschmer A, Brönner J, Hoedlmoser H, Husser O, Kasel AM, Lange R, Tassani-Prell P.

PLoS One. 2019 Jan 30;14(1):e0210872. doi: 10.1371/journal.pone.0210872. eCollection 2019.

2.

Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Núñez J, Joner M, Trenkwalder T, Mayr NP, Holdenrieder S, Bodi V, Koenig W, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Oct 25. pii: S1885-5857(18)30390-6. doi: 10.1016/j.rec.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30482731
3.

Critical adverse events during transfemoral TAVR in conscious sedation. Is an anesthesiologic support mandatory?

Mayr NP, Wiesner G, Husser O, Joner M, Michel J, Knorr J, Pellegrini C, Bleiziffer S, Schunkert H, Lange R, Tassani-Prell P.

Cardiovasc Revasc Med. 2018 Sep;19(6S):41-46. doi: 10.1016/j.carrev.2018.06.014. Epub 2018 Jun 21.

PMID:
30327095
4.

Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction.

Trenkwalder T, Pellegrini C, Holzamer A, Rheude T, Riester J, Reinhard W, Mayr NP, Kasel AM, Gaede L, Blumenstein J, Kastrati A, Schunkert H, Joner M, Hilker M, Hengstenberg C, Husser O.

Clin Res Cardiol. 2018 Aug 28. doi: 10.1007/s00392-018-1364-6. [Epub ahead of print]

PMID:
30155732
5.

Multicenter Evaluation of Prosthesis Oversizing of the SAPIEN 3 Transcatheter Heart Valve. Impact on Device Failure and New Pacemaker Implantations.

Pellegrini C, Kim WK, Holzamer A, Walther T, Mayr NP, Michel J, Rheude T, Nuñez J, Kasel AM, Trenkwalder T, Kaess BM, Joner M, Kastrati A, Schunkert H, Hilker M, Möllmann H, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Jul 14. pii: S1885-5857(18)30239-1. doi: 10.1016/j.rec.2018.06.005. [Epub ahead of print] English, Spanish.

PMID:
30017841
6.

Predictors of Need for Permanent Pacemaker Implantation and Conduction Abnormalities With a Novel Self-expanding Transcatheter Heart Valve.

Pellegrini C, Husser O, Kim WK, Holzamer A, Walther T, Rheude T, Mayr NP, Trenkwalder T, Joner M, Michel J, Chaustre F, Kastrati A, Schunkert H, Burgdorf C, Hilker M, Möllmann H, Hengstenberg C.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):145-153. doi: 10.1016/j.rec.2018.01.011. Epub 2018 Mar 16. English, Spanish.

PMID:
29551701
7.

Incidental findings in multislice computed tomography prior to transcatheter aortic valve implantation: frequency, clinical relevance and outcome.

Trenkwalder T, Lahmann AL, Nowicka M, Pellegrini C, Rheude T, Mayr NP, Voss S, Bleiziffer S, Lange R, Joner M, Kasel AM, Kastrati A, Schunkert H, Husser O, Hadamitzky M, Hengstenberg C.

Int J Cardiovasc Imaging. 2018 Jun;34(6):985-992. doi: 10.1007/s10554-018-1305-5. Epub 2018 Feb 21.

PMID:
29468355
8.

Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support.

Mayr NP, Wiesner G, van der Starre P, Hapfelmeier A, Goppel G, Kasel AM, Hengstenberg C, Husser O, Schunkert H, Tassani-Prell P.

Can J Anaesth. 2018 Jun;65(6):647-657. doi: 10.1007/s12630-018-1092-4. Epub 2018 Feb 20.

PMID:
29464420
9.

Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Schmid H, Trenkwalder T, Mayr NP, Joner M, Kasel AM, Holdenrieder S, Nunez J, Sanchis J, Bodi V, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Am J Cardiol. 2018 Feb 15;121(4):461-468. doi: 10.1016/j.amjcard.2017.11.020. Epub 2017 Nov 27.

PMID:
29306485
10.

Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Reinhard W, Trenkwalder T, Koenig W, Mayr NP, Joner M, Núñez J, Holdenrieder S, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Biomarkers. 2018 May;23(3):299-304. doi: 10.1080/1354750X.2018.1423706. Epub 2018 Jan 15.

PMID:
29297708
11.

Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.

Trenkwalder T, Pellegrini C, Holzamer A, Philipp A, Rheude T, Michel J, Reinhard W, Joner M, Kasel AM, Kastrati A, Schunkert H, Endemann D, Debl K, Mayr NP, Hilker M, Hengstenberg C, Husser O.

Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27385. [Epub ahead of print]

PMID:
29130616
12.

Periprocedural transfusion in patients undergoing transfemoral transcatheter aortic valve implantation.

Mayr NP, Wiesner G, Hapfelmeier A, van der Starre P, Husser O, Bleiziffer S, Schunkert H, Lange R, Tassani-Prell P, Martin K.

Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27382. [Epub ahead of print]

PMID:
29130582
13.

Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Michel J, Trenkwalder T, Mayr NP, Kessler T, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Int J Cardiol. 2017 Oct 1;244:93-99. doi: 10.1016/j.ijcard.2017.06.024. Epub 2017 Jun 13.

PMID:
28645804
14.

Comment to: De Waha S, Seeburger J et al. (2016): Deep sedation versus general anaesthesia in percutaneous edge-to edge mitral valve reconstruction using the MitraClip system. Clin Res Cardiol 105(6):535-43.

Wiesner G, Tassani-Prell P, Mayr NP.

Clin Res Cardiol. 2017 Feb;106(2):160-161. doi: 10.1007/s00392-016-1046-1. Epub 2016 Nov 4. No abstract available.

PMID:
27815637
15.

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve.

Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C.

JACC Cardiovasc Interv. 2016 Feb 8;9(3):244-254. doi: 10.1016/j.jcin.2015.09.036.

16.

Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.

Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Ott I, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C.

JACC Cardiovasc Interv. 2015 Dec 21;8(14):1809-16. doi: 10.1016/j.jcin.2015.08.014.

17.

Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI).

Mayr NP, Michel J, Bleiziffer S, Tassani P, Martin K.

J Thorac Dis. 2015 Sep;7(9):1518-26. doi: 10.3978/j.issn.2072-1439.2015.08.21. Review.

18.

Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcome†.

Mayr NP, Hapfelmeier A, Martin K, Kurz A, van der Starre P, Babik B, Mazzitelli D, Lange R, Wiesner G, Tassani-Prell P.

Br J Anaesth. 2016 Jan;116(1):90-9. doi: 10.1093/bja/aev294. Epub 2015 Sep 29.

19.

Structural valve deterioration 4 years after transcatheter aortic valve replacement: imaging and pathohistological findings.

Deutsch MA, Mayr NP, Assmann G, Will A, Krane M, Piazza N, Bleiziffer S, Lange R.

Circulation. 2015 Feb 17;131(7):682-5. doi: 10.1161/CIRCULATIONAHA.114.013995. No abstract available.

PMID:
25691705
20.

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome.

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Br J Anaesth. 2013 Apr;110(4):615-21. doi: 10.1093/bja/aes430. Epub 2012 Dec 4.

Supplemental Content

Support Center